PEAK6 Group’s Juno Therapeutics, Inc. JUNO Stock Holding History

PEAK6 Group’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-35,500	Closed	-$1.62M	–	5335
2017 Q4	$1.62M	Sell	35,500 -6,900	-16%	-$344K	0.01%	1569
2017 Q3	$1.9M	Buy	42,400 +20,000	+89%	+$682K	0.01%	1432
2017 Q2	$670K	Hold	22,400	–	–	﹤0.01%	2275
2017 Q1	$497K	Sell	22,400 -26,000	-54%	-$558K	﹤0.01%	2267
2016 Q4	$912K	Hold	48,400	–	–	0.01%	1957
2016 Q3	$1.45M	Buy	+48,400	New	+$1.51M	0.01%	1502
2016 Q2	–	Sell	-50,000	Closed	-$1.91M	–	5117
2016 Q1	$1.91M	Buy	+50,000	New	+$1.74M	0.02%	1189

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

PEAK6 Group's JUNO Position: Q1 2018 in Review

PEAK6 Group sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 2,716 shares — an estimated $124K sold.

PEAK6 Group first reported a position in JUNO in Q1 2016 and held it in 7 quarters. The position peaked at $1.04M in Q1 2016. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

PEAK6 Group reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
PEAK6 Group sold 2,716 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $124K.
PEAK6 Group first reported a position in Juno Therapeutics, Inc. in Q1 2016 and held it in 7 quarters.
PEAK6 Group's Juno Therapeutics, Inc. position peaked at $1.04M in Q1 2016.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on PEAK6 Group's 13F filing for Q1 2018, filed 15 May 2018.